Concept information
...
Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)
Product containing pembrolizumab (medicinal product)
Product containing pembrolizumab in parenteral dosage form (medicinal product form)
Product containing only pembrolizumab in parenteral dose form (medicinal product form)
...
Product containing programmed cell death protein 1 inhibitor (product)
Product containing pembrolizumab (medicinal product)
Product containing pembrolizumab in parenteral dosage form (medicinal product form)
Product containing only pembrolizumab in parenteral dose form (medicinal product form)
Preferred term
Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Type
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
Broader concept
Has basis of strength substance
Has manufactured dose form
Has precise active ingredient
Has presentation strength denominator unit
Has presentation strength numerator unit
Has unit of presentation
Plays role
In other languages
URI
http://www.irandoc.acir/onto/irandoc/787884004
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}